Published in Gen Pharmacol on January 01, 1993
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A (1994) 4.15
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med (1996) 2.28
Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J (1995) 1.74
Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med (2003) 1.69
Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis (1999) 1.42
Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest (1995) 1.33
Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. J Neurosci (2009) 1.10
Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach. Br J Pharmacol (1999) 1.07
mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators". Biochimie (2010) 1.07
Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol (2001) 1.03
Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility. World J Gastroenterol (2012) 1.02
Effects of selective inhibitors of cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2) on the spontaneous myogenic contractions in the upper urinary tract of the guinea-pig and rat. Br J Pharmacol (2000) 1.00
Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem J (1995) 0.99
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. Br J Pharmacol (2005) 0.99
Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISH cells. Biochem J (1997) 0.96
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. Trends Pharmacol Sci (2014) 0.95
Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig Dis Sci (1998) 0.95
Diverse methyl sulfone-containing benzo[b]thiophene library via iodocyclization and palladium-catalyzed coupling. J Comb Chem (2010) 0.94
The structure of NS-398 bound to cyclooxygenase-2. J Struct Biol (2011) 0.91
Dual, but not selective, COX-1 and COX-2 inhibitors, attenuate acetic acid-evoked bladder irritation in the anaesthetised female cat. Br J Pharmacol (2006) 0.89
Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am J Pathol (2006) 0.87
The calcium ionophore A23187 induces endothelium-dependent contractions in femoral arteries from rats with streptozotocin-induced diabetes. Br J Pharmacol (2007) 0.87
Identification of a novel class of anti-inflammatory compounds with anti-tumor activity in colorectal and lung cancers. Invest New Drugs (2011) 0.87
Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. Br J Pharmacol (2002) 0.86
The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat. Inflammation (1998) 0.85
Intraplantar-injected ceramide in rats induces hyperalgesia through an NF-κB- and p38 kinase-dependent cyclooxygenase 2/prostaglandin E2 pathway. FASEB J (2011) 0.85
Cyclooxygenase-2 and its regulation in inflammation. Mediators Inflamm (1996) 0.84
Disparate effects of non-steroidal anti-inflammatory drugs on apoptosis in guinea-pig gastric mucous cells: inhibition of basal apoptosis by diclofenac. Br J Pharmacol (2002) 0.83
Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages. PLoS One (2012) 0.83
Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats. Br J Pharmacol (2000) 0.82
Ex vivo effects of lysine clonixinate on cyclooxygenases in rat lung and stomach preparations. Inflammopharmacology (1999) 0.79
LPS and TNF alpha modulate AMPA/NMDA receptor subunit expression and induce PGE2 and glutamate release in preterm fetal ovine mixed glial cultures. J Neuroinflammation (2013) 0.77
Aspirin Intolerance: Experimental Models for Bed-to-Bench. Curr Drug Targets (2016) 0.75
Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol (1991) 5.03
Limb and skin abnormalities in mice lacking IKKalpha. Science (1999) 3.85
Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology (1992) 3.22
Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J (1999) 3.19
Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol (1993) 2.90
Univalent reduction of molecular oxygen by spinach chloroplasts on illumination. J Biol Chem (1974) 2.63
Visualization of single molecules of RNA polymerase sliding along DNA. Science (1993) 2.63
Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum (2000) 2.61
NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins (1994) 2.60
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci U S A (1998) 2.12
Superoxide dismutases from a blue-green alga, Plectonema boryanum. J Biol Chem (1975) 2.11
Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci U S A (1997) 1.97
Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet (1994) 1.91
Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg (2001) 1.83
Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci U S A (1994) 1.81
Bone metastasis of gastric cancer. Jpn J Surg (1983) 1.77
Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem (1994) 1.76
Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res (1996) 1.74
Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol (1996) 1.72
Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis (1998) 1.70
Retained surgical sponges: CT and US appearance. Radiology (1987) 1.67
Archaeal adaptation to higher temperatures revealed by genomic sequence of Thermoplasma volcanium. Proc Natl Acad Sci U S A (2000) 1.67
Endoscopic submucosal dissection for early gastric cancers and large flat adenomas. Endoscopy (2006) 1.66
Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther (2001) 1.65
Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J Biol Chem (1984) 1.63
Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes. J Gen Virol (1986) 1.59
Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol (1994) 1.59
Association between genetic variants of mast-cell chymase and eczema. Lancet (1996) 1.57
Arytenoid cartilage dislocation caused by a double-lumen endobronchial tube. Br J Anaesth (2005) 1.57
The effect of long-term medical therapy on the outcome of filtration surgery. Am J Ophthalmol (1994) 1.55
Phlebosclerosis of the colon with positive anti-centromere antibody. Intern Med (1999) 1.55
Cystic lesions of the maxillomandibular region: MR imaging distinction of odontogenic keratocysts and ameloblastomas from other cysts. AJR Am J Roentgenol (1996) 1.52
The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups. J Gen Virol (1998) 1.52
Gas Sensing Based on a Nonlinear Response: Discrimination between Hydrocarbons and Quantification of Individual Components in a Gas Mixture. Anal Chem (1996) 1.50
Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis (2001) 1.49
Changes in locomotor activity and passive avoidance task performance induced by cerebral ischemia in Mongolian gerbils. Stroke (1994) 1.46
Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann Neurol (1995) 1.46
Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol (1995) 1.46
A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest (2000) 1.45
Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3) Br J Dermatol (1997) 1.44
Regulation of keratin 9 in nonpalmoplantar keratinocytes by palmoplantar fibroblasts through epithelial-mesenchymal interactions. J Invest Dermatol (1999) 1.44
Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics. Alcohol Clin Exp Res (1999) 1.43
The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease. J Gen Virol (1994) 1.41
Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer. J Nucl Med (2000) 1.40
Epidemiologic investigation of the relative clearance of haloperidol by mixed-effect modeling using routine clinical pharmacokinetic data in Japanese patients. J Clin Psychopharmacol (2000) 1.38
Roentgenological study of the sagittal diameter of the cervical spinal canal in normal adult Japanese. Neurol Med Chir (Tokyo) (1998) 1.37
MR tractography for the evaluation of functional recovery from lenticulostriate infarcts. Neurology (2005) 1.36
Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population. Ther Drug Monit (1998) 1.36
Syringocystadenocarcinoma papilliferum: case report and immunohistochemical comparison with its benign counterpart. J Am Acad Dermatol (2001) 1.33
Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J Biol Chem (1998) 1.33
Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat Med (2001) 1.33
Physical and functional interactions of neuronal growth suppressor necdin with p53. J Biol Chem (1999) 1.31
The entire nucleotide sequence of a TT virus isolate from the United States (TUS01): comparison with reported isolates and phylogenetic analysis. Virology (1999) 1.30
Cloning and characterization of molecular isoforms of the catalytic subunit of calcineurin using nonisotopic methods. J Biol Chem (1990) 1.30
Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity (2001) 1.29
Primary mutagenicity screening of food additives currently used in Japan. Food Chem Toxicol (1984) 1.29
Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet (1997) 1.28
Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res (1991) 1.28
Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp Clin Res (1989) 1.27
A novel polymorphism (-357 G/A) of the ALDH2 gene: linkage disequilibrium and an association with alcoholism. Alcohol Clin Exp Res (1999) 1.26
High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein. Oncology (2000) 1.26
Mutation rate of GB virus C/hepatitis G virus over the entire genome and in subgenomic regions. Virology (1997) 1.26
Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity. J Biochem (1989) 1.25
A possible dual control mechanism in the origin of peptic ulcer. A study on ulcer location as affected by mucosa and musculature. Gastroenterology (1969) 1.24
Taxonomical studies of Acinetobacter species--cellular fatty acid composition. Z Allg Mikrobiol (1979) 1.24
Endoscopic submucosal dissection for rectal tumors. Endoscopy (2007) 1.24
Ameloblastoma in the maxillomandibular region: MR imaging. Radiology (1992) 1.23
A preliminay investigation on the molecular structure of rice dwarf virus ribonucleic acid. J Mol Biol (1966) 1.23
Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Hum Mol Genet (2001) 1.23
Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. J Nucl Med (1992) 1.22
Cutaneous wound healing: an update. J Dermatol (2001) 1.22
Mid-brain pathology of Wilson's disease: MRI analysis of three cases. J Neurol Neurosurg Psychiatry (1991) 1.21
Genetic analysis of obese diabetes in the TSOD mouse. Diabetes (1999) 1.21
Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol (2009) 1.20
Cloning of genes coding for L-sorbose and L-sorbosone dehydrogenases from Gluconobacter oxydans and microbial production of 2-keto-L-gulonate, a precursor of L-ascorbic acid, in a recombinant G. oxydans strain. Appl Environ Microbiol (1997) 1.20
Polymerase chain reaction for the detection of Mycobacterium tuberculosis in ocular tuberculosis. Am J Ophthalmol (1994) 1.19
Posttransfusion fulminant hepatitis B associated with precore-defective HBV mutants. Vox Sang (1991) 1.19
Presenilin-1 polymorphism and Alzheimer's disease. Lancet (1996) 1.18
Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus. Pharmacogenetics (2000) 1.18
Formation of n-decene-1 from n-decane by resting cells of Candida rugosa. Z Allg Mikrobiol (1969) 1.18
The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet (1997) 1.17
A novel brain-specific mRNA encoding nuclear protein (necdin) expressed in neurally differentiated embryonal carcinoma cells. Biochem Biophys Res Commun (1991) 1.17
Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma. Br J Cancer (2001) 1.17
Purification, molecular cloning, and expression of lipase from Pseudomonas aeruginosa. Arch Biochem Biophys (1992) 1.16
L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J Virol (1998) 1.16
A novel epidermal cell differentiation inhibitor (EDIN): purification and characterization from Staphylococcus aureus. Biochem Biophys Res Commun (1990) 1.16
Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp Dermatol (2006) 1.15
Raman diagnosis of nucleic acid structure: sugar-puckering and glycosidic conformation in the guanosine moiety. Nucleic Acids Res (1983) 1.15
Wave emission from heterogeneities opens a way to controlling chaos in the heart. Phys Rev Lett (2007) 1.15
Cystic neoplasms of the pancreas: comparison of MR imaging with CT. Radiology (1989) 1.15
Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans. Clin Pharmacol Ther (2008) 1.15
Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line. J Virol (1997) 1.14
Variation of major neutral oligosaccharides levels in human colostrum. Eur J Clin Nutr (2007) 1.14
Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenomics J (2006) 1.14
Reversible MRI and CT findings in uremic encephalopathy. Neuroradiology (1991) 1.13
Identification of 197 genetic variations in six human methyltranferase genes in the Japanese population. J Hum Genet (2001) 1.12
Concentrations of sialyloligosaccharides in bovine colostrum and milk during the prepartum and early lactation. J Dairy Sci (2003) 1.11